The use of psychedelics as medicine has opened up a new industry growing exponentially at a rapid pace
As attitudes shift we are witnessing an international rise in clinical psychedelic trials academic research and commercial investment
The global psychedelics industry is expected to be worth over US$100 billion with the potential to save $1 trillion on lost productivity disrupting the way we approach healthcare
We highlight key psychedelic players, innovations and milestones, providing trustworthy insights to help investors cut through the noise and identify real opportunities.
We provide perspective on the societal impacts of modernising regulations and improving access to psychedelics, revealing the real cost-benefit of collective mental healing.
We connect operators to a qualified audience with access to capital, ready to support industry growth and help them achieve their goals. Our global psychedelics intelligence illuminates foriegn markets.
Interested in partnering with PSYCH, media opportunities or speaking at the next Investor Summit? Send us your information and thoughts on how we can collaborate.